The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Platelets in inflammation and atherogenesis
Open accessAbstract
Platelets represent an important linkage between inflammation, thrombosis, and atherogenesis. Inflammation is characterized by interactions among platelets, leukocytes, and ECs. These interactions trigger autocrine and paracrine activation processes that lead to leukocyte recruitment into the vascular wall. Platelet-induced chronic inflammatory processes at the vascular wall result in development of atherosclerotic lesions and atherothrombosis. This Review highlights the molecular machinery and inflammatory pathways used by platelets to initiate and accelerate atherothrombosis.Platelet interaction with endothelium At the site of vascular lesions, ECM proteins such as vWF and collagen are exposed to the blood.Platelet adhesion to the exposed matrix is considered to be the initial step in thrombus formation.Platelets adhere to vWF via the membrane adhesion receptor glycoprotein Ib/IX/V (GPIb/IX/V) (1) and to collagen via GPVI (2-4).This results in platelet activation and transformation of the integrin receptors α IIb β 3 (GPIIb/IIIa, fibrinogen receptor) (5, 6) and α 2 β 1 (collagen receptor) (4, 7), which firmly bind to the respective ECM components.Subsequently, platelets spread and form a surface for the recruitment of additional platelets via fibrinogen bridges between 2 α IIb β 3 receptors.In vitro studies with human ECs.In recent years, however, it has become increasingly evident that endothelial denudation is not an absolute prerequisite to allow platelet attachment to the arterial wall.The intact, nonactivated endothelium normally prevents platelet adhesion to the ECM.The adhesion receptors involved in platelet attachment to the subendothelial matrix, e.g., following rupture of an atherosclerotic plaque, have been well defined during the past decade; however, the molecular determinants that promote the interaction between platelets and endothelium are incompletely understood.Whereas endothelium normally controls platelet reactivity through inhibitory and modulating mechanisms involving COX-2, PGI 2 , or prostanoid synthetic systems, inflamed ECs develop properties that render them adhesive for platelets.In vitro studies showed that platelets adhere to the intact but activated human EC monolayer (8-10).Platelet adhesion to human umbilical vein ECs (HUVECs) is mediated by a GPIIb/IIIa-dependent bridging mechanism involving platelet-bound fibrinogen, fibronectin, and vWF (10).In HUVECs infected with herpes virus or stimulated with IL-1, platelet adhesion was effectively inhibited by antibodies to vWF or α IIb β 3 integrin, respectively (9,11,12).Furthermore, the involvement of the EC receptors ICAM-1, α v β 3 integrin, and GPIb in the binding of activated platelets to HUVECs has been described in vitro (10).In vivo studies of mouse models.Most in vitro studies have evaluated platelet-endothelium adhesion to human ECs under static conditions with limited attention to the dynamic situation in Nonstandard abbreviations used: CD40L, CD40 ligand; GP, glycoprotein; HUVEC, human umbilical vein EC; MCP-1, monocyte chemoattractant protein-1; PF4, platelet factor 4; uPAR, urokinase-type plasminogen activator receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Ruggeri, Z. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1227 · Cited by 1,589
Platelet-collagen interaction: is GPVI the central receptor?
Nieswandt, B., & Watson, S. P. (2003) · Blood · doi:10.1182/blood-2002-12-3882 · Cited by 1,150
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation
Massberg, S., Brand, K., Grüner, S., Page, S., Müller, E., Müller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012044 · Cited by 879
Self-citationCoppinger, J. A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., McRedmond, J. P., Cahill, D. J., Emili, A., Fitzgerald, D. J., & Maguire, P. B. (2004) · Blood · doi:10.1182/blood-2003-08-2804 · Cited by 814
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Cited by
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Self-citationPlatelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692
Akt signalling in health and disease
Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,239
Platelet α-granules: Basic biology and clinical correlates
Blair, P., & Flaumenhaft, R. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.001 · Cited by 1,157
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis
CHU, S. G., BECKER, R. C., BERGER, P. B., BHATT, D. L., EIKELBOOM, J. W., KONKLE, B., MOHLER, E. R., REILLY, M. P., & BERGER, J. S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03584.x · Cited by 1,043
Platelet secretion: From haemostasis to wound healing and beyond
Golebiewska, E. M., & Poole, A. W. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.10.003 · Cited by 930
Adhesion Mechanisms in Platelet Function
Ruggeri, Z. M., & Mendolicchio, G. L. (2007) · Circulation Research · doi:10.1161/01.res.0000267878.97021.ab · Cited by 755
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
Arterial thrombosis—insidious, unpredictable and deadly
Jackson, S. P. (2011) · Nature Medicine · doi:10.1038/nm.2515 · Cited by 685
The immune system and cardiac repair
FRANGOGIANNIS, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.007 · Cited by 641
Platelet functions beyond hemostasis
SMYTH, S. S., MCEVER, R. P., WEYRICH, A. S., MORRELL, C. N., HOFFMAN, M. R., AREPALLY, G. M., FRENCH, P. A., DAUERMAN, H. L., & BECKER, R. C. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03586.x · Cited by 584
The role of saliva in tick feeding
Francischetti, I. (2009) · Frontiers in Bioscience · doi:10.2741/3363 · Cited by 581
The Hemostatic System as a Modulator of Atherosclerosis
Borissoff, J. I., Spronk, H. M. H., & ten Cate, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011670 · Cited by 569
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Jennings, L. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0192 · Cited by 436
Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0379-5 · Cited by 398
Self-citationEndothelial-Dependent Mechanisms of Leukocyte Recruitment to the Vascular Wall
Rao, R. M., Yang, L., Garcia-Cardena, G., & Luscinskas, F. W. (2007) · Circulation Research · doi:10.1161/circresaha.107.151860b · Cited by 394
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease
Swirski, F. K., Pittet, M. J., Kircher, M. F., Aikawa, E., Jaffer, F. A., Libby, P., & Weissleder, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604260103 · Cited by 367
Platelet-derived HMGB1 is a critical mediator of thrombosis
Vogel, S., Bodenstein, R., Chen, Q., Feil, S., Feil, R., Rheinlaender, J., Schäffer, T. E., Bohn, E., Frick, J.-S., Borst, O., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81660 · Cited by 370
Self-citationChronic urticaria and autoimmunity: Associations found in a large population study
Confino-Cohen, R., Chodick, G., Shalev, V., Leshno, M., Kimhi, O., & Goldberg, A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.043 · Cited by 369
The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases
Vizioli, L., Muscari, S., & Muscari, A. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02070.x · Cited by 369
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
Takayama, N., Nishimura, S., Nakamura, S., Shimizu, T., Ohnishi, R., Endo, H., Yamaguchi, T., Otsu, M., Nishimura, K., Nakanishi, M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100844 · Cited by 349
Leukocyte – endothelial interactions in inflammation
Langer, H. F., & Chavakis, T. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00811.x · Cited by 344
Wei, X., Ying, M., Dehaini, D., Su, Y., Kroll, A. V., Zhou, J., Gao, W., Fang, R. H., Chien, S., & Zhang, L. (2018) · ACS Nano · doi:10.1021/acsnano.7b07720 · Cited by 329
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
Dziedzic, E. A., Gąsior, J. S., Tuzimek, A., Paleczny, J., Junka, A., Dąbrowski, M., & Jankowski, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179553 · Cited by 319
The Role of Platelets in Atherothrombosis
Kaplan, Z. S., & Jackson, S. P. (2011) · Hematology · doi:10.1182/asheducation-2011.1.51 · Cited by 307
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00579 · Cited by 307
Semple, J. W., & Freedman, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0205-1 · Cited by 303
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
Lievens, D., Zernecke, A., Seijkens, T., Soehnlein, O., Beckers, L., Munnix, I. C. A., Wijnands, E., Goossens, P., van Kruchten, R., Thevissen, L., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261206 · Cited by 301
van Gils, J. M., Zwaginga, J. J., & Hordijk, P. L. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708400 · Cited by 298
Gary, T., Pichler, M., Belaj, K., Hafner, F., Gerger, A., Froehlich, H., Eller, P., Rief, P., Hackl, G., Pilger, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067688 · Cited by 296
Fibronectin in development and wound healing
Patten, J., & Wang, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.005 · Cited by 295
Stellos, K., Langer, H., Daub, K., Schoenberger, T., Gauss, A., Geisler, T., Bigalke, B., Mueller, I., Schumm, M., Schaefer, I., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.714691 · Cited by 290
Self-citationAzeredo, E. L. D., Monteiro, R. Q., & de-Oliveira Pinto, L. M. (2015) · Mediators of Inflammation · doi:10.1155/2015/313842 · Cited by 288
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
Intertwining of thrombosis and inflammation in atherosclerosis
Croce, K., & Libby, P. (2007) · Current Opinion in Hematology · doi:10.1097/00062752-200701000-00011 · Cited by 284
Platelet-derived chemokines in inflammation and atherosclerosis
Bakogiannis, C., Sachse, M., Stamatelopoulos, K., & Stellos, K. (2019) · Cytokine · doi:10.1016/j.cyto.2017.09.013 · Cited by 281
Endothelial Cellular Responses to Biodegradable Metal Zinc
Ma, J., Zhao, N., & Zhu, D. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00319 · Cited by 275
Hundelshausen, P. V., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 271
Platelets in Inflammation and Atherogenesis
Nording, H. M., Seizer, P., & Langer, H. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00098 · Cited by 254
RUGGERI, Z. M. (2009) · Microcirculation · doi:10.1080/10739680802651477 · Cited by 253
Candemir, M., Kiziltunç, E., Nurkoç, S., & Şahinarslan, A. (2021) · Angiology · doi:10.1177/0003319720987743 · Cited by 181
Song, Y., Zhao, Y., Shu, Y., Zhang, L., Cheng, W., Wang, L., Shu, M., Xue, B., Wang, R., Feng, Z., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1100453 · Cited by 141
“Frontiers in Endocrinology 07 atherosclerosis: their adherence to the vascular wall promotes plaque formation (42), whereas their activation promotes inflammation and thrombosis (43).”
BackgroundErdoğan, M., Erdöl, M. A., Öztürk, S., & Durmaz, T. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0274 · Cited by 128
Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
Ta, H. T., Truong, N. P., Whittaker, A. K., Davis, T. P., & Peter, K. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1316262 · Cited by 105
Rahman, K., Lowe, G. M., & Smith, S. (2016) · The Journal of Nutrition · doi:10.3945/jn.114.202408 · Cited by 43
Zhou, Y., Luo, Y., Liang, H., Zhong, P., & Wu, D. (2023) · BMC Neurology · doi:10.1186/s12883-023-03365-6 · Cited by 11
Mueller, K. A. L., Langnau, C., Harm, T., Sigle, M., Mott, K., Droppa, M., Borst, O., Rohlfing, A.-K., Gekeler, S., Günter, M., et al. (2024) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.124.321000 · Cited by 7
Self-citation
Metadata
- Authors
- Gawaz, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-12-01
- Volume
- 115
- Issue
- 12
- Pages
- 3378-3384
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2615170291
- Cited by
- 1,468
- References
- 81
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.